RCE 2.06% 49.5¢ recce pharmaceuticals ltd

News: RCE Recce Pharmaceuticals Announces Positive Preclinical Efficacy Data Against Who Priority...

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    July 10 (Reuters) - Recce Pharmaceuticals Ltd (RCE) :

    • RECCE PHARMACEUTICALS LTD - R327 DEMONSTRATES 99.99999% LOG REDUCTION IN A. BAUMANNII
    • RECCE PHARMACEUTICALS ANNOUNCES POSITIVE PRECLINICAL EFFICACY DATA AGAINST WHO PRIORITY PATHOGEN ACINETOBACTER BAUMANNII
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
49.5¢
Change
0.010(2.06%)
Mkt cap ! $114.6M
Open High Low Value Volume
48.5¢ 51.0¢ 48.5¢ $1.909K 3.908K

Buyers (Bids)

No. Vol. Price($)
4 15775 48.5¢
 

Sellers (Offers)

Price($) Vol. No.
49.5¢ 66869 2
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.